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Studies of active pharmaceutical ingredient (API) - excipient compatibility represent an 
important study in the preformulation stage of the development of new dosage forms. The 
potential physical and chemical interactions between an API and the excipients can affect the 
chemical nature, the stability and bioavailability of the former and, consequently, its therapeutic 
efficacy and safety. Solid dosage forms are generally less stable than their API components. 
Despite the importance of API-excipient compatibility testing, there is no universally accepted 
protocol to assess such interactions.  
Fourier Transform Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), 
Isothermal Stress Testing-Fourier Transform Infrared Spectroscopy (IST-FT-IR), Isothermal 
Stress Testing-High Performance Liquid Chromatography (IST-HPLC), are commonly used as 
screening techniques for assessing the compatibility of an active pharmaceutical ingredient 
(API) with some currently employed excipients. Through the assignment of spectral bands, 
FTIR provides information on chemical reactions taking place between the API and the 
excipient. Thus, this procedure gives formulation scientists information on which chemical 




The stability, chemical structure and bioavailability of an 
API are affected by interactions taking place between the 
API and the excipients. These alterations lead to a 
reduced therapeutic efficacy and safety [1]. As a rule, 
solid dosage forms are less stable than the isolated API. 
Although it has already been established that API-
excipient compatibility testing must always be carried out 
during the development of new dosage forms, a 
consensus on the test to be employed is still lacking [2,3]. 
The most common signs of deterioration of an API are 
changes in color, taste, odor, polymorphic form, or 
crystallization (pharmaceutical incompatibility).These 
changes arise from chemical reactions with the excipient, 
leading to degradation of the API [4].  
Thermo-analytical techniques have been developed to 
predict the suitability of the excipients to be employed in 
dosage forms in order to minimize undesired reactions 
(stability issues) between the API and the excipient [4]. In 
this sense, physico-chemical interactions between the API 
and excipients can be readily evaluated by differential 
scanning calorimetry (DSC) [5-16]. Some authors claim; 
however, that the data obtained by thermal techniques are 
difficult to interpret and that the interactions observed at 
high temperatures during DSC assays may not be 
representative of those occurring under normal storage 
conditions [17]. 
Isothermal stress testing-high performance liquid 
chromatography (IST-HPLC), Fourier transform infrared 
spectroscopy (FTIR) and powder X-ray diffraction 
(PDRX) are other methods to study API-excipient 
compatibility. The IST-HPLC involves storing the API-
excipient blends at high temperature followed by the 
determination of the API content by HPLC [18-21]. Some 
authors use PDRX to evaluate compatibility of API with 
excipients [22-25]. 
FTIR spectroscopy is not only useful to study the 
behavior of solid state APIs and their excipients but also 
as a compatibility screening tool, since the vibrational 
changes detected by this method serve as evidence for 
potential intermolecular interactions among the dosage 
components. 
FTIR is recommended as a simple technique for the 
detection of interactions between the API and the 
excipients [16, 21, 22, 26-36] or between different APIs 
[37]. A reduction of the peak intensity, the appearance of 
an absorption peak, or the appearance of new peaks 
indicate the existence of interactions between the 
excipient and the API [17, 18, 34, 38]. 
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FTIR and DSC 
It has been suggested that the interactions observed at 
high temperatures during DSC experiments might not be 
representative of those occurring at normal storage 
temperatures [17, 18, 39, 40]. 
The instrument that determines the absorption spectrum 
for a compound is called a spectrophotometer. Fourier 
transform spectrophotometer provides the IR spectrum 
much more rapidly compared to the traditional 
spectrophotometer. 
The IR spectrum obtained from FTIR spectrometer lies in 
the mid-IR region 2.5-15 µm between 4000 and 666 cm_1. 
Transition energies corresponding to changes in 
vibrational energy state for many functional groups are in 
the mid-IR region (4000-400 cm_1) and hence the 
appearance of an absorption band in this region can be 
used to determine whether specific functional groups 
exist within the molecule. There are four regions of types 
of bonds that can be analyzed from the FTIR spectra, 
single bond (OH, CH, and NH) is detectable in higher 
wavenumber (2500-4000 cm_1). The triple bond and 
double bond are detectable in the middle wavenumber 
region 2000-2500 cm_1 and 1500-2000 cm_1, respectively. 
At low wavenumber region 650-1500 cm-1 can be used 
for the identification of the molecule as a whole. 
FTIR is a simple methodology for the detection of 
variations within drug-excipient blends. The 
disappearance of an absorption peak, a reduction of the 
peak intensity, or the appearance of new peaks are 
indicative of the existence of interactions between the 
API and the excipient under study [17, 18, 34, 38]. 
By DSC, Daniel et al. [41] have studied the compatibility 
of binary mixtures (1:1) of risperidone and 
pharmaceutical excipients. These binary mixtures were 
also kept at room temperature and then analyzed by FT-
IR in combination with principal component analysis 
(PCA) to evaluate solid-state incompatibilities. 
Lima et al. [42] have studied the compatibility of 
trioxalen with sodium lauryl sulfate by DSC, DTA, and 
FTIR at 25°C, 240°C (after the fusion event) and 260°C. 
Figure 1 shows that trioxalen peak of fusion disappear in 
the mixture (1:1) with sodium lauryl sulphate. The 
trioxalen bands in the FTIR spectrum of the mixture (1:1) 
with sodium lauryl sulphate were well retained, indicating 
no change in the structure of the drug at room 
temperature (Figure 2). Same results were obtained 
before the mixture were heated at 240°C and 260°C (data 
not shown). It was concluded that trioxalen is compatible 
with sodium lauryl sulphate. 
 
Figure 1. DSC curves of (1) TX, (2) TX/SLS, 3 (SLS). Reprinted with permission from Lima NGPB, Lima IPB, Barros 
DMC,  Oliveira TS, Raffin FN, de Lima e Moura TFA, Medeiros ACD, Gomes APB, Aragão CFS: Compatibility 
studies of trioxsalen with excipients by DSC, DTA, and FTIR, J Therm Anal Cal 2014; 115:2311-2318. Copyright (2019) 
Springer Nature.  
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Figure 2. IR spectra of (1) TX, (2) TX/SLS, (3) SLS at 25°C. Reprinted with permission from Lima NGPB, Lima IPB, 
Barros DMC,  Oliveira TS, Raffin FN, de Lima e Moura TFA, Medeiros ACD, Gomes APB, Aragão CFS: 
Compatibility studies of trioxsalen with excipients by DSC, DTA, and FTIR, J Therm Anal Cal 2014; 115:2311-2318. 
Copyright (2019) Springer Nature.  
FTIR is a valuable tool to evaluate the compatibility of 
drugs without melting point. By DSC, Veiga et al. [21] 
have studied the compatibility of omeprazole sodium 
monohydrate with excipients such as, microcrystalline 
cellulose, croscarmellose sodium, colloidal silicon 
dioxide, starch 1500, sodium starch glycolate, magnesium 
stearate, sodium carbonate, Acryl-Eze, stearic-acid and 
citric acid. The authors considered the decomposition 
exothermic peak of the API as an incompatibility 
parameter. These results were then confirmed by Diffuse 
Reflectance Infrared Fourier Transform Spectroscopy 
(DRIFT). 
IST – FTIR and HPLC 
Isothermal stress testing (IST) is another method used in 
compatibility testing. For this method, the drug-excipient 
blends are stored at high temperatures with or without 
moisture. The drug content is then determined by a 
suitable method, usually HPLC [18-21] or FTIR [16, 20, 
26, 29, 30, 43]. 
Stress testing could be performed by storing physical 
mixtures in accelerated conditions at 40°C and 75% RH 
for 3 months [16], at ambient temperature, at 40°C and 
75% RH and at 40°C and 75 % RH with the addition of 
100 µL of distilled water for 4 days [43], 14 days at 50°C 
[20], three weeks at 55°C [26, 29], and four weeks at 
50°C [30]. 
Unlike the results obtained after 12 weeks using HPLC, 
Liltorp et al. [17] have demonstrated that IST/FT-IR can 
detect potential compatibility problems between an API 
and the excipients after only 3 days of storage at 50°C 
and 95% RH. The authors indicate that the spectrum of 
Lu AA44608 HBr-Mg stearate, before and after the 
storage at 50°C and 95% RH present theappearance of a 
new peak at ∼3270 cm−1that was also observed in the 
spectrum of the free-base compound. Several other peaks 
corresponding to the free base compound are marked in 
the spectrum. These changes correspond to the desalting 
of the hydrogen bromide salt.  
FTIR supported by multivariate statistics 
Rojek and Wesolowski [44] have suggested that the 
presence of overlapping bands in the FTIR spectra may 
difficult the analysis. The spectra obtained in their work 
were more accurate and informative because the authors 
used an interferometer instead of amonochromator.   
To improve the information quality indirectly acquired 
form the FTIR spectra, a multivariate statistics method, 
such as principal component analysis (PCA), should be 
carried out. Rojek and Wesolowski performed a 
compatibility study in different blends of atenolol and β-
cyclodextrin, methylcellulose, starch and chitosan. The 
authors selected two spectral regions (3600–2800 cm-1 
and 1800–1000 cm-1) for multivariate statistical 
calculations. Changes in the structure of atenolol were 
readily detected because the region between 1800-1000 
cm-1 does not present typical absorption bands of 
excipients. 
The results obtained by FTIR spectroscopy, supported by 
multivariate statistical methods, were verified by DSC, 
TG and PDRX. 
FTIR and Pearson’s correlation analysis 
Silva et al. [34] have studied the compatibility between 
atorvastatin and excipients. They compared the 
atorvastatin spectra at 25°C with heated atorvastatin in 
binary mixtures. The Pearson’s correlation analysis was 
employed in an algorithm to compare spectra over ever 
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decreasing spectral ranges. Two spectra are compared 
firstly as a whole and then each half of the spectra, each 
of half of the halves and so forth. The correlation values 
for each section are assigned to a vector with the same 
length of the spectra range being compared. A final 
average correlation vector is then obtained. This average 
is used to compare the spectra. The experimental 
spectrum can also be derived from a theoretical spectrum 
of the pure compound through a multivariate linear 
regression. This methodology assumes that the spectrum 
corresponding to the mixture is the result of the 
superposition the spectra of the pure compounds. When 
the experimental and theoretical spectra are different, it 
can be assumed that the atoms or the whole molecules 
have undergone a rearrangement within the mixture. 
Correlation values near 1.0 indicate lack of significant 
interactions between the mixture constituents. Low 
correlations may arise from noise (or baseline); if such is 
the case, no further evaluations are made. Correlation 
values between 0.80 and 1.00 are considered high and 
indicate the presence of simple solid mixtures. Moderate 
correlations are between 0.50 and 0.80, and they may 
indicate the presence of interactions. Values below 0.50 
indicate low similarity between spectra, demonstrating 
chemical degradation. The Pearson´s correlation between 
atorvastatin and nine excipients can be seen in Figure 3. 
Barros Lima et al. [45] have studied the compatibility 
between tretinoin and pharmaceutical excipients using the 
Pearson’s correlation.  
 
 
Figure 3. Person´s correlation of atorvastatin + excipients sodium lauryl sulphate, croscarmellose, pre-gelatinized starch, 
microcrystalline cellulose 101 (MC101), lactose, sodium starch glycolate, microcrystalline cellulose 102 (MC102) and (9) 
magnesium stearate (10) mannitol. Reprinted with permission from da Silva EP, Pereira MAV, de Barros Lima IP, 
Barros Lima NGP, Barboza EG, Aragã CFS, Gomes APB: Compatibility study between atorvastatin and excipients 
using DSC and FTIR J Therm Anal Cal 2016; 123:933-939. Copyright (2019) Springer Nature. 
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FTIR advantages and disadvantages in 
compatibility studies 
When compared to other analytical methods, FTIR has 
several advantages:  a) it is a common quality control 
equipment, b) this method detects changes in the crystal 
structure, i.e. polymorphic changes, desalting, and degree 
of hydration; c) the preparation of samples is easy; d) 
useful for API without melting point, e) can detect 
potential incompatibility between an API and 
pharmaceutical excipients after a few days of storage with 
control temperature and humidity, f) the use of the 
interferometer instead of the classical monochromator 
makes the spectra obtained more accurate and 
informative. 
FTIR has the disadvantages: a) It is not helpful with 
overlapping peaks, b) sometimes it requires the 
application of statistical analysis for interpretation, c) It is 
necessary to combine with IST. 
Conclusion 
Studies on drug–excipient compatibility represent an 
important step in the formulation stage for the 
development of all dosage forms. Despite its 
disadvantages, FTIR is a simple technique available in 
analytical laboratories. 
Through the assignment of spectral bands, FTIR provides 
information on chemical reactions taking place between 
the API and the excipient. Thus, this procedure gives 
formulation scientists information on which chemical 
groups to avoid in the excipients, favoring the 
development of more stable blends.  
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